Business · 22/03/2022Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting to Discuss COVID-19 Vaccine Booster Doses and Strain Selection
Summary
The FDA is hosting a public meeting of the Vaccines and Related Biological Products Advisory Committee to discuss COVID-19 vaccine booster doses and strain selection, with public comments invited through a newly established docket.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →